CHIL first connected with partners from Burkina Faso at Medlab Middle East 2019, where they were already familiar with the Chil’s global achievements and expertise. During the event, the foundations of a strategic partnership were agreed upon, establishing clear terms for collaboration. This partnership led to CHIL’s first export to Burkina Faso in May 2019, marking another milestone in expanding access to reliable diagnostics in emerging markets.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.